| Issue Date | Title | Author(s) |
| 29-Aug-2019 | Dolutegravir plus two different prodrugs of tenofovir to treat HIV | Venter, WDF; Moorhouse, M; Sokhela, S; Fairlie, L; Mashabane, N, et al |
| 11-Aug-2020 | Patient portal functionalities and patient outcomes among diabetes patients: a systematic | Alturkistani, A; Qavi, A; Anyanwu, PE; Greenfield, G; Greaves, F, et al |
| 11-Aug-2020 | Patient portal functionalities and patient outcomes among patients with diabetes: systematic review (Preprint) | Alturkistani, A; Qavi, A; Anyanwu, PE; Greenfield, G; Greaves, F, et al |
| 19-Aug-2020 | Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial | Sadeghi, A; Ali Asgari, A; Norouzi, A; Kheiri, Z; Anushirvani, A, et al |
| 1-Jul-2020 | The ADVANCE trial: Phase 3, randomised comparison of TAF/FTC plus DTG, TDF/FTC plus DTG or TDF/FTC/EFV for first-line treatment of HIV-1 infection | Venter, F; Sokhela, S; Fairlie, L; Serenata, C; Mashabane, N, et al |
| 1-Jul-2022 | Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis | Whittaker, C; Watson, O; Alvarez-Moreno, C; Angkasekwinai, N; Boonyasiri, A, et al |